Larvol Delta - STAR-First-in-Human-Study-With-NG641-a-Tumour-Selective-Transgene-Expressing-Adenoviral-Vector

NG-641 - Akamis Bio

http://clinicaltrials.gov/ct2/show/NCT04053283

Jan 18, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next